Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Mayo Clin Proc. 2014 Jun 27;89(11):1515–1524. doi: 10.1016/j.mayocp.2014.04.015

Table 5.

Summary of Subtypes and Etiologies of Leukocytoclastic Vasculitis

Subtype No. (%)
Palpable purpura (predominant)
 CSVV (n=38)
  Idiopathic 29 (76)
  ACTDa 2 (5)
  Infectionb 6 (16)
  Drug reactionc 1 (3)
 IgA vasculitis (n=25)
  Idiopathic 24 (96)
  Infectiond 1 (4)
 ANCA-associated vasculitis (n=8)
  Microscopic polyangiitis 1 (12.5)
  Granulomatosis with polyangiitis 2 (25)
  Eosinophilic granulomatosis with polyangiitis 2 (25)
  p-ANCA, NOS 2 (25)
  c-ANCA, NOS 1 (12.5)
 Cryoglobulinemic vasculitis (n=3)
  ACTDe 1 (33)
  Infectionf 2 (67)
Urticaria-like lesions
 Urticarial vasculitis (n=10)
  Normocomplementemic 8 (80)g
   Idiopathic 6 (75)
   Infectionh 1(12.5)
   Drug reactioni 1 (12.5)
  Hypocomplementemic 2 (20)
   ACTDj 2 (100)

Abbreviations: ACTD, autoimmune connective tissue disease; ANCA, antineutrophil cytoplasmic antibody; c-ANCA, cytoplasmic ANCA; CSVV, cutaneous small-vessel vasculitis; NOS, not otherwise specified; p-ANCA, perinuclear ANCA.

a

Sjögren syndrome and systemic lupus erythematosus in 1 patient each.

b

Hepatitis C in 2 patients and hepatitis B and C, parvovirus, pneumonia, and streptococcal infection in 1 patient each.

c

Amoxicillin.

d

Streptococcal infection.

e

Rheumatoid arthritis.

f

Hepatitis C.

g

Complements were not checked in 2 patients.

h

Hepatitis C.

i

Epoetin alfa.

j

Systemic lupus erythematosus and mixed connective tissue disease in 1 patient each.